Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea

被引:51
|
作者
Raveh, David
Rabinowitz, Bella
Breuer, Gabriel S.
Rudensky, Bernard
Yinnon, Amos M.
机构
[1] Shaare Zedek Med Ctr, Infect Dis Unit, IL-91031 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Jerusalem, Israel
[3] Shaare Zedek Med Ctr, Dept Med, IL-91031 Jerusalem, Israel
[4] Shaare Zedek Med Ctr, Clin Microbiol Lab, IL-91031 Jerusalem, Israel
[5] Hebrew Univ Jerusalem, Fac Med, Sch Med, Jerusalem, Israel
关键词
diarrhoea; Clostridium difficile; antibiotic-associated colitis; pseudomembranous colitis; nosocomial infections;
D O I
10.1016/j.ijantimicag.2006.04.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Data were retrieved from the records of all patients from whom stool was sent for Clostridium difficile toxin testing during the year 2001. Toxin-positive and -negative patients were compared by bivariate analysis and regression models. Eight hundred samples from 610 patients were sent for C. difficile toxin testing. Charts of 535 patients (88%) were available for analysis. Of those, 17% had a positive toxin test whilst 83% had a negative toxin test. There was no difference in the number of daily bowel movements between the two groups. Toxin-positive patients were older (P < 0.0001), more often came from nursing homes (P < 0.05), had higher leukocyte counts (P < 0.001), higher blood urea nitrogen (P < 0.01), lower serum albumin (P < 0.01) and more often received diuretics (P < 0.01) and clindamycin (P < 0.05). Logistic regression analysis showed that previous antibiotic-associated diarrhoea was the most significant risk factor for toxin-positive diarrhoea (P < 0.001), followed by clindamycin treatment (P < 0.005), diuretics (P < 0.005) and older age (P < 0.05). Another logistic model showed the contribution of macrolides (P < 0.05) to the development of hospital-acquired diarrhoea. (c) 2006 Published by Elsevier B.V. and the International Society of Chemotherapy.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 50 条
  • [31] Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly
    Starr, JM
    Impallomeni, M
    BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (02) : 63 - 67
  • [32] Audit of the antimicrobial treatment of Clostridium difficile toxin-positive episodes using an integrated electronic prescribing, information and communication system
    Jumaa, P.
    Young, I.
    Nightingale, P.
    Clark, I.
    JOURNAL OF HOSPITAL INFECTION, 2009, 72 (04) : 371 - 373
  • [33] Emergence of a Novel Binary Toxin-Positive Strain of Clostridium difficile Associated With Severe Diarrhea That Was Not Ribotype 027 and 078 in China
    Li, Chunhui
    Liu, Sidi
    Zhou, Pengcheng
    Duan, Juping
    Dou, Qingya
    Zhang, Rui
    Chen, Hong
    Cheng, Ying
    Wu, Anhua
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (09): : 1112 - 1114
  • [34] Risk Factors for Clostridium difficile Toxin Positive Diarrhea, a Population Based Prospective Case Control Study
    Vesteinsdottir, Iris
    Einarsdottir, Rannveig A.
    Gudlaugsdottir, Sunna
    Jonasdottir, Alda
    Bjornsson, Einar
    GASTROENTEROLOGY, 2011, 140 (05) : S60 - S60
  • [35] Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078
    Tagashira, Yasuaki
    Kato, Haru
    Senoh, Mitsutoshi
    Nakamura, Akira
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 1486 - 1489
  • [36] Clostridium difficile infections in HIV-positive patients with diarrhoea
    Kumar, N.
    Ekka, M.
    Raghunandan, P.
    Chaudhry, R.
    Sharma, N.
    Ranjan, S.
    Ahmad, H.
    Samantaray, J. C.
    Sharma, S. K.
    Sreenivas, V.
    Sinha, S.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2014, 27 (03): : 138 - 140
  • [37] Clarithromycin and risk of Clostridium difficile-associated diarrhoea
    Wilcox, MH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (03) : 358 - 359
  • [38] Antimicrobial Susceptibilities and Molecular Characterization of Toxin-Positive Clostridium difficile Isolates: The First Report on the Presence of Hypervirulent Strains from Turkey
    Salman, Emrah
    Levent, Belkis
    Karahan, Zeynep Ceren
    MIKROBIYOLOJI BULTENI, 2017, 51 (03): : 236 - 246
  • [39] Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital
    Changela, U
    Cannon, JP
    Aneziokoro, C
    Shah, PS
    Thottapurathu, L
    Lentino, J
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (06) : 562 - 566
  • [40] Diarrhoea associated to Clostridium difficile
    Puente, RZ
    Farinas, MC
    Palomo, JDG
    Balbin, JA
    MEDICINA CLINICA, 1998, 110 (09): : 359 - 359